Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United Kingdom
/
Healthcare
/
Integrated Diagnostics Holdings
IDHC
Integrated Diagnostics Holdings
Egypt, Nigeria Risks Will Curtail Prospects Yet Saudi Will Emerge
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
29 Jul 25
Updated
10 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$0.46
10.2% undervalued
intrinsic discount
10 Aug
US$0.41
Loading
1Y
10.8%
7D
10.8%
Author's Valuation
US$0.5
10.2% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$0.5
10.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
11b
2014
2017
2020
2023
2025
2026
2028
Revenue ج.م10.8b
Earnings ج.م2.0b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
17.09%
Healthcare Services revenue growth rate
0.27%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.82%
Calculation
ج.م2.05b
Earnings '28
x
6.97x
PE Ratio '28
=
ج.م14.27b
Market Cap '28
ج.م14.27b
Market Cap '28
/
528.72m
No. shares '28
=
ج.م26.99
Share Price '28
ج.م26.99
Share Price '28
Discounted to 2025 @ 6.82% p.a.
=
ج.م22.14
Fair Value '25
ج.م22.14
Fair Value '25
Converted to USD @ 0.0206 EGP/USD Exchange Rate
=
US$0.46
Fair Value '25
